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Abstract
Background: Persistent digestive disorders account for considerable disease burden in the tropics. Despite advances
in understanding acute gastrointestinal infections, important issues concerning epidemiology, diagnosis, treatment and
control of most persistent digestive symptomatologies remain to be elucidated. Helminths and intestinal protozoa are
considered to play major roles, but the full extent of the aetiologic spectrum is still unclear. We provide an overview of
pathogens causing digestive disorders in the tropics and evaluate available reference tests.
Methods: We searched the literature to identify pathogens that might give rise to persistent diarrhoea, chronic
abdominal pain and/or blood in the stool. We reviewed existing laboratory diagnostic methods for each pathogen and
stratified them by (i) microscopy; (ii) culture techniques; (iii) immunological tests; and (iv) molecular methods.
Pathogen-specific reference tests providing highest diagnostic accuracy are described in greater detail.
Results: Over 30 pathogens may cause persistent digestive disorders. Bacteria, viruses and parasites are important
aetiologic agents of acute and long-lasting symptomatologies. An integrated approach, consisting of stool culture,
microscopy and/or specific immunological techniques for toxin, antigen and antibody detection, is required for
accurate diagnosis of bacteria and parasites. Molecular techniques are essential for sensitive diagnosis of many viruses,
bacteria and intestinal protozoa, and are increasingly utilised as adjuncts for helminth identification.
Conclusions: Diagnosis of the broad spectrum of intestinal pathogens is often cumbersome. There is a need for rapid
diagnostic tests that are simple and affordable for resource-constrained settings, so that the management of patients
suffering from persistent digestive disorders can be improved.
Keywords: Bacteria, Clinical microbiology, Diagnosis, Digestive disorders, Gastroenterology, Helminths, Intestinal
protozoa, Persistent diarrhoea, Virus
Background
Diarrhoeal diseases and other digestive disorders are
leading causes of morbidity and mortality worldwide,
with the highest burden concentrated in tropical and
subtropical areas that often lack access to clean water
and adequate sanitation, and where hygienic conditions
are generally poor [1]. According to the World Health
Organization (WHO), diarrhoea is classified into three
different categories, namely (i) acute watery diarrhoea
(lasting several hours or days); (ii) acute bloody diar-
rhoea (synonymous: dysentery); and (iii) persistent diar-
rhoea (lasting 14 days or longer) [2]. ‘Chronic diarrhoea’
is often referred to as an individual term applicable to
diarrhoea lasting more than 4–6 weeks, but it still lacks
an unambiguous definition.
With an estimated burden of 89.5 million disability-
adjusted life years (DALYs) caused in 2010, diarrhoeal
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diseases rank fourth in the recently published Global
Burden of Disease Study [3]. Acute diarrhoeal episodes
are mainly due to bacterial and viral pathogens that may
cause a variety of clinical syndromes ranging from self-
limiting events to life-threatening diseases. Children are
most vulnerable and diarrhoeal diseases were responsible
for more than 1.4 million deaths in 2010, ranking this
disorder at position seven on the main causes of death
[4]. In the last decades, concerted efforts have consider-
ably improved our understanding of the epidemiology,
diagnosis, treatment and control of many diarrhoeagenic
pathogens globally, for instance due to the introduction
of rotavirus vaccination programmes in many countries
since 2006 [5]. As a result, mortality due to diarrhoeal
diseases has been reduced from an estimated 2.5 million
in 1990 to just under 1.5 million in 2010, a decrease of
42% [4]. However, few research activities have focused on
the investigation of persistent diarrhoea and non-acute ab-
dominal pain due to digestive disorders in the tropics.
Hence, little is known regarding its aetiology, epidemi-
ology and disease burden. It is widely acknowledged that
intestinal parasites, particularly helminths and intestinal
protozoa play a major role as causative agents of persistent
digestive symptomatologies [6].
Infections with helminths and intestinal protozoa belong
to the neglected tropical diseases, along with other diseases
caused by bacterial (e.g. Buruli ulcer), viral (e.g. dengue)
and fungal infections (e.g. mycetoma) [7]. More than 5 bil-
lion people are at risk of neglected tropical diseases, with
the common soil-transmitted helminths (i.e. Ascaris lum-
bricoides, hookworm and Trichuris trichiura), exhibiting
the widest geographical distribution [8]. Due to their intim-
ate connection with poverty, the highest prevalences of
neglected tropical diseases are observed in remote rural
and deprived urban settings in the developing world
[7,9,10]. Neglected tropical diseases drain the social and
economic development in endemic countries and they
negatively impact on people’s quality of life and well-being
at all levels [11-15].
A major challenge in the clinical management of persist-
ent digestive disorders is the weakness of health systems
in many low-income countries [16-18]. Hence, affected
people might only seek care at a late stage in their
therapeutic itinerary, usually at primary health care cen-
tres [19,20]. However, these primary health care centres
are often under-staffed and ill-equipped, resulting in a low
quality of care. The causes of persistent diarrhoea and
other digestive disorders are frequently misdiagnosed due
to the often unspecific clinical presentations and the
absence of evidence-based algorithms for in-depth investi-
gation [7,21]. The notorious underfinancing of health
systems in many tropical and subtropical countries
explains the severe neglect of laboratory networks and the
only limited availability of basic tests for diagnostic
services (e.g. direct faecal smears for helminth diagnosis
or blood films for malaria diagnosis) [22]. Hence, in many
developing countries, current diagnostic and treatment
algorithms are often empirical, whereas local prevalence
data and differential diagnoses are rarely taken into ac-
count at the primary care level.
Against this background, NIDIAG, an international col-
laboration on integrated diagnosis-treatment platforms,
funded by the European Commission, sets out to develop
an improved system for delivering primary health care in
resource-constrained settings and proposes an integrated
approach to this challenge. Emphasis is placed on a
patient-centred approach starting from the presentation at
the primary health care level of a clinical syndrome that
might be due to ‘common’ pathogens. Three clinical syn-
dromes will be investigated in the NIDIAG framework,
namely (1) neurological disorders [23]; (2) persistent fever
[24]; and (3) digestive disorders. Here, we focus on digest-
ive disorders, which we define as (i) persistent (≥2 weeks)
abdominal pain; (ii) persistent (≥2 weeks) diarrhoea
(dysenteric or non-dysenteric); and/or (iii) blood in the
stool. These digestive disorders will be investigated at dif-
ferent study sites in tropical areas of Africa (Côte d’Ivoire
and Mali) and Asia (Indonesia and Nepal). Before clinic-
ally applicable diagnosis-treatment algorithms can be
developed, the following major challenges/open issues
have to be addressed. Firstly, few studies analysed the
spectrum of intestinal pathogens causing persistent digest-
ive disorders in the tropics. Therefore, epidemiological
investigations targeting all potential pathogens are desir-
able to define the most common bacteria, parasites and
viruses in the different study settings. Secondly, most diag-
nostic tests have only been validated in Western settings,
and hence their diagnostic accuracy in the tropics remains
to be determined.
In this manuscript, pursuing an extensive literature re-
view complemented with expert opinion, we provide an
overview of potential pathogens (bacterial, parasitic and
viral) that might give rise to digestive disorders as
defined above. Available diagnostic tests for the identi-
fied pathogens are summarised and reviewed, and we
propose pathogen-specific reference tests to be utilised
for an in-depth diagnostic work-up of symptomatic
patients in the different study sites.
Methods
Framework
A symptomatology according to the aforementioned in-
clusion criteria for the syndrome of digestive disorders is
likely to be caused by a large variety of infections, but
also non-infectious diseases. For example, blood in the
stool, accompanied by persistent abdominal pain, may
be indicative of colorectal carcinoma or inflammatory
disorders (e.g. Crohn’s disease and ulcerative colitis), but
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may also be a sign of Schistosoma mansoni (a helminth)
or Entamoeba histolytica (an intestinal protozoon) infec-
tion. The aim of the NIDIAG project is to develop
evidence-based diagnosis-treatment algorithms that can
easily be applied in resource-constrained health care set-
tings. As neither diagnosis nor treatment of many non-
infectious diseases are currently feasible in remote rural
areas of most developing countries, only infectious
aetiologies of digestive disorders that may cause severe
disease and that are treatable will be thoroughly assessed
within the frame of the NIDIAG project and were there-
fore prioritised in our literature search.
Search strategy, data extraction and analysis
We performed a literature review to identify and define
the bacterial, parasitic and viral pathogens that may give
rise to persistent diarrhoea and chronic digestive disor-
ders, and to obtain information on their respective diag-
nostic methods in order to describe appropriate reference
laboratory tests. Since the role of fungi as causative patho-
gens of gastrointestinal infections is still under debate,
fungal infections were not included in this review [25].
The available literature was reviewed by three independent
groups. The results were compared, discussed and finally
synthesised. Additionally, a number of experts were con-
sulted to complement the literature review.
In a first step, we examined a series of textbooks
pertaining to medical bacteriology, parasitology and vir-
ology. Moreover, we searched the electronic database
MEDLINE/PubMed for infectious pathogens that may
cause digestive disorders as defined in the inclusion cri-
teria. After having identified a set of more than 30 patho-
gens, we searched the database with the following search
term for all infectious agents: “disease name/[Mesh]” and
the subheading “diagnosis” (e.g. “ascariasis/diagnosis”
[Mesh]). The focus of the MEDLINE/PubMed search was
on established laboratory tests as well as on newer diag-
nostic methods, which have been validated recently or are
currently under validation (e.g. studies objectively asses-
sing the diagnostic accuracy of different tests). Hence, we
primarily focused on reviews, comparative studies and
evaluation studies. Our search had no language or other
restrictions and we included studies that were published
until mid-April 2012.
Results
Our literature review revealed more than 30 bacterial,
parasitic and viral pathogens that may cause persistent di-
gestive disorders. Many of these infectious agents are epi-
demiologically well characterised in Western settings,
while data regarding their occurrence in tropical and sub-
tropical areas are scarce and often contradictory [6,26-28].
Table 1 provides a list of all selected pathogens and typical
clinical characteristics that may assist clinicians to curtail
their differential diagnosis. However, pathogen-specific
diagnosis can rarely be done based on the clinical presen-
tations, and hence additional diagnostic tools are needed.
The large number of available diagnostic tests for the
selected pathogens is a challenge for providing the single
most accurate method for a given pathogen. Hence, we
classified the different methods into four diagnostic cat-
egories, namely (i) microscopy; (ii) culture; (iii) immun-
ology (including enzyme immunoassays (EIA), serotyping
of isolates and serology); and (iv) molecular biological
diagnosis (e.g. polymerase chain reaction (PCR) assays and
DNA sequencing). Selection of a reference test for each
specific pathogen is primarily based on the sensitivity and
specificity of the test as well as practical considerations (e.
g. costs, ease of application, availability, etc.). The results
are presented in Table 2 (bacteria), Table 3 (intestinal
protozoa), Table 4 (helminths) and Table 5 (viruses). Spe-
cific issues on the diagnostic work-up are summarised in
the following sub-chapters.
Bacterial pathogens
Aeromonas spp., Campylobacter jejuni, C. coli, Plesiomonas
shigelloides, Salmonella enterica (non-typhoidal serovars, e.
g. S. enterica ser. Enteritidis, S. enterica ser. Typhimurium),
Shigella spp., Vibrio spp., Yersinia enterocolitica, Y.
pseudotuberculosis
A stool culture on selective media is the test of choice to
detect these diarrhoeagenic bacteria [31,48,50,52,53].
Different solid media (e.g. selective agar plates containing
antibiotics and substances favouring the growth of the
sought microorganism) are inoculated with a stool speci-
men to detect and isolate enteric pathogens. The add-
itional use of a selective enrichment broth is helpful to
identify pathogenic bacteria if their presence is quantita-
tively so low that they might otherwise be overlooked on
solid media due to the overgrowth of non-pathogenic in-
testinal flora. The inoculated media are usually incubated
for 24–72 hours at 35°C at ambient atmosphere to allow
the bacteria to form macroscopically visible colonies. Of
note, Campylobacter spp. are isolated using different
growth conditions, i.e. incubation at a higher temperature
of 42°C in microaerophilic atmosphere [53].
Following the incubation period, the agar plates are
examined and morphologically suspicious colonies are
identified using different biochemical identification panels
or automated phenotypic identification systems (e.g. VitekW;
bioMérieux, Marcy l’Étoile, France). Recently, more rapid
identification algorithms making use of mass spectrometry
(MS) have successfully been implemented into clinical
microbiology laboratories (e.g. matrix-assisted laser des-
orption ionization time-of-flight (MALDI-TOF) MS (e.g.
MicroFlex LT; Bruker Daltonics, Bremen, Germany) [98].
Stool culture remains the diagnostic ‘gold’ standard for
enteric pathogenic bacteria disposing certain characteristics
Becker et al. BMC Infectious Diseases 2013, 13:37 Page 3 of 21
http://www.biomedcentral.com/1471-2334/13/37
which enable them to be selected out of the normal gastro-
intestinal flora, while other bacteria without such charac-
teristics cannot be distinguished from apathogenic gut
bacteria by culture methods alone (see below). Stool cul-
ture has important advantages, such as testing of isolated
pathogens for antimicrobial susceptibility. As the successful
antibiotic treatment of many bacterial intestinal infections
requires knowledge of local resistance patterns (e.g. extent
of fluoroquinolone-resistant Campylobacter strains), stool
culture techniques remain mandatory to guide therapeutic
interventions. However, these tests are laborious and re-
quire experienced personnel, and typically take 48–72 hours
to obtain first results. Hence, other, more rapid diagnostic
tests (RDTs) have been developed for some pathogens. For
Campylobacter spp., for example, EIAs detecting a specific
antigen in the stool proved to be a sensitive alternative to
stool culture with results available within a few hours
[32,99]. However, there is no international consensus on
Table 1 Overview of intestinal pathogens (bacteria,
intestinal protozoa, helminths and viruses) that may
cause persistent digestive disorders in infected individuals
Enteric pathogen Persistent
diarrhoea
Persistent
abdominal
pain
Blood in
the stool
Bacteria
Aeromonas spp. + – –
Campylobacter jejuni, C. coli + + +
Clostridium difficile + + +
Escherichia coli
Enteroaggregative E. coli
(EAEC)
+ + +
Enteropathogenic E. coli
(EPEC)
+ + –
Enteroinvasive E. coli (EIEC) + + +
Enterohaemorrhagic E. coli
(STEC/EHEC)
+ + +
Enterotoxigenic E. coli (ETEC) + + –
Diffusely adherent E. coli
(DAEC)
+ – –
Mycobacterium tuberculosis and
atypical mycobacteria
+ + +
Plesiomonas shigelloides + – –
Salmonella enterica (typhoidal
and non-typhoidal serovars)
+ + +
Shigella spp. + + +
Tropheryma whipplei + – –
Vibrio spp. + – –
Yersinia enterocolitica,
Y. pseudotuberculosis
+ – –
Intestinal protozoa
Balantidium coli + + +
Blastocystis hominisa (+) (+) –
Cryptosporidium spp. + + –
Cyclospora cayetanensis + – –
Dientamoeba fragilisa + + –
Entamoeba histolytica + + +
Giardia intestinalis (syn.: G.
lamblia and G. duodenalis)
+ + –
Isospora belli (syn.: Cystoisospora
belli)
+ (+) –
Species of microsporidia + + –
Helminths
Cestodes
Diphyllobothrium latum + + –
Hymenolepis spp. + – –
Taenia spp. + + –
Nematodes
Ascaris lumbricoides + + –
Table 1 Overview of intestinal pathogens (bacteria,
intestinal protozoa, helminths and viruses) that may
cause persistent digestive disorders in infected individuals
(Continued)
Capillaria philippinensis + + –
Hookworm (Ancylostoma
duodenale and Necator
americanus)
+ + –
Strongyloides stercoralis + + (+)
Trichuris trichiura + + –
Trematodes
Intestinal flukes + + –
Intestinal blood flukes:
Schistosoma mansoni,
S. intercalatum, S. japonicum,
S. mekongi
+ + +
Viruses
Adenovirus + – –
Astrovirus (+) – –
Bocavirus (+) – –
Coronavirus (+) – –
Cytomegalovirus (CMV) + + +
Enterovirus + – –
Human immunodeficiency virus
(HIV-1/2)
+ + –
Norovirus + – –
Parechovirus (+) – –
Rotavirus + + –
Sapovirus (+) – –
+, existing risk; (+), low risk; –, no risk.
a There is an ongoing debate whether these intestinal protozoa have
pathogenic potential or should rather be seen as simple commensals of the
gastrointestinal tract [29,30].
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immunological assays for detection of Campylobacter spp.
and no globally validated and standardised approach, so
that these tools should not replace the selective stool cul-
ture [100]. PCR assays, characterised by high sensitivity and
specificity, have been developed for most of the aforemen-
tioned bacteria. Thus far, however, integration into clinical
routine testing is still limited. Important drawbacks are the
high cost, the need for sophisticated laboratory equipment
and well-trained laboratory technicians. Moreover, PCR
cannot distinguish between dead or alive bacteria and does
not allow testing for antimicrobial susceptibility. However,
newly developed multiplex PCR assays are increasingly
being evaluated as fast screening tests for early detection of
various important enteric pathogens. Besides PCR, novel
molecular diagnostics are currently being developed and
validated for many bacterial and viral pathogens, e.g. loop-
mediated isothermal amplification (LAMP) assays. Results
obtained thus far are promising [101,102], but it remains to
be elucidated whether such nucleic acid amplification tests
can be employed on a larger scale in resource-constrained
settings in the tropics.
Salmonella enterica ser. Typhi/Paratyphi
Diagnosis of enteric fever is challenging and often
delayed or not performed due to the unavailability of
the most sensitive techniques in areas of high endem-
icity [103]. In these settings, the Widal test (measuring
an increasing S. Typhi-specific antibody titer over the
course of 10 days in patient serum samples) is often the
only available test, despite its poor diagnostic perform-
ance. Contrary to non-typhoidal salmonellosis, stool
culture is not sufficiently sensitive to diagnose infection
due to S. Typhi/S. Paratyphi. Culturing blood and bone
marrow is more sensitive, but bone marrow aspiration
is only rarely performed in tropical areas due to a lack
of adequately equipped hospitals and laboratories [104].
Blood cultures should be obtained during the first week
of disease to achieve adequate sensitivity [45]. Serotyp-
ing of isolates (e.g. by agglutination of Vi antigen or rapid
detection of various antigens or IgM antibodies by differ-
ent EIA kits) is helpful for a timely diagnosis, but lacks
sensitivity and specificity [46]. PCR assays have been
developed for different antigens of invasive S. enterica ser-
ovars, but still need further development and validation
before they can be more widely recommended [105].
Clostridium difficile
C. difficile can be found as part of the physiological intes-
tinal flora, but toxin-producing strains may cause severe
diarrhoea, which is most frequently seen in hospitalised
patients who recently received antibiotic treatment [33].
A selective stool culture (toxigenic culture, performed
on a selective agar medium or after ethanol shock
pretreatment) followed by tests for toxin production
remains the diagnostic ‘gold’ standard for C. difficile [33]
and is particularly useful when the quantity of toxins in
stool samples is small [34]. A laborious and technically
difficult cell culture cytotoxicity assay is still regarded as
an alternative reference standard, but is seldom per-
formed in most microbiological laboratories. More re-
cently developed PCR assays targeting a toxin-encoding
gene are currently discussed as an alternative method
for early diagnosis of C. difficile infection. Such molecu-
lar methods allow a more precise characterisation of iso-
lated C. difficile strains, e.g. ribotype differentiation
[35,106,107]. Sensitivity and specificity of PCR have been
reported to vary between 85% and 100% [108]. However,
various molecular assays exist which are not yet fully
standardised, and the diagnostic performance of com-
mercially available kits may differ considerably from in-
house molecular testing methods in use at different
laboratories. Of note, PCR can only prove the presence
of the toxin-encoding gene, but cannot distinguish be-
tween asymptomatic carriage and acute infection.
In clinical practice, an easily applicable two-step ap-
proach is recommended for rapid and reasonably sen-
sitive diagnosis of C. difficile [109]. Firstly, a screening
test for C. difficile-associated glutamate dehydrogenase
(GDH) should be performed to indicate the bacter-
ium’s presence in a stool sample. If positive, it should
be followed by a test for toxin production (e.g. toxin
A/B EIA). This procedure does not require an exten-
sively equipped laboratory and generates accurate
results within a few hours. However, the sensitivity and
specificity of this two-step approach are limited, and
hence toxigenic culture and PCR testing should always
be performed when there is a high clinical suspicion
despite negative test results [110].
Pathogenic Escherichia coli strains
Diagnosis of pathogenic E. coli is challenging, as these bac-
teria constitute an important part of the physiological in-
testinal flora and only some strains have diarrhoeagenic
potential [41]. There are at least six groups of pathogenic
E. coli strains, namely (i) diffusely adherent (DAEC);
(ii) enteroaggregrative (EAEC); (iii) enterohaemorrhagic
(EHEC, including STEC = shiga toxin-producing E. coli);
(iv) enteroinvasive (EIEC); (v) enteropathogenic (EPEC);
and (vi) enterotoxigenic E. coli (ETEC). Pathogenic E. coli
strains that carry simultaneously virulence factors from dif-
ferent pathotypes may cause severe clinical outbreaks. In
mid-2011 in Germany, for example, the E. coli strain O104:
H4 (an EAEC capable of EHEC/STEC-specific shiga toxin
production) caused 2,987 cases of acute, often severe
gastroenteritis and 855 cases of haemolytic-uraemic syn-
drome which led to 53 deaths [111].
While diagnostic procedures are poorly standardised
for the pathotypes DAEC and EAEC, molecular
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Table 2 Diagnostic tests for important bacterial pathogens that may cause persistent digestive disorders
Infectious
pathogen
Diagnostic method
Microscopy Stool culture Immunology Molecular biology (PCR) Reference(s)
Aeromonas spp. -a Culture on
cefsulodin-irgasan-
novobiocin (CIN) or
selective Aeromonas
agar
- (Experimental, not validated) [31]
Campylobacter
jejuni, C. coli
Darkfield microscopy:
motile, curved or S-
shaped rods (suggestive
of Campylobacter spp.)
Culture on selective
mediumb (42°C,
microaerophilic
conditions)
• Faecal antigen
enzyme
immunoassay:
Campylobacter-
specific antigen (SA)
hipO gene (C. jejuni), glyA gene (C.
coli)
[32]
• Serology (important
for diagnosis of
postinfectious
immunological
diseases)
Clostridium difficile -c Culture on selective
medium, e.g.
cycloserin-cefoxitin-
fructose agar (CCF) +
toxigenic culture
• 2-step algorithm: Toxin genes (increasingly being
used in clinical routine)
[33-35]
1) Screening: EIA for
glutamate
dehydrogenase
(GDH)
2) ELISA for detection
of toxin A and B
• Cell cytotoxicity assay
for detection of toxin A
and B
Escherichia coli
Enteroaggregative -a HEp-2 cell adherence
assay (following
incubation in Luria
broth)
• Serology: antibody
response against
Plasmid-encoded toxin
(Pet)
AggR, CVD432, EAST1 (most
common virulence factors, not
always present)
[36]
E. coli (EAEC)
• ELISA: secretory
immunoglobulin A
response to EAEC
Enteropathogenic E.
coli (EPEC)
-a Culture on MacConkey
(MAC) agar
- eae gene [37]
Enteroinvasive E.
coli (EIEC)
-a Culture on MAC agar ELISA: detection of the
ipaC gene
ipaH, ipaB genes [38]
Enterohaemorrhagic -a Culture on sorbitol-
MAC agar (most O157:
H7 strains form
sorbitol-negative
colonies)
• O157 latex
agglutination test
STEC: stx1, stx2 genes [39,40]
E. coli (EHEC
including STEC)
• Shiga toxins 1 & 2
(ELISA)
EHEC: stx1/stx2 + eae gene
Enterotoxigenic E.
coli (ETEC)
-a Culture on MAC agar Several immunoassays
for toxin detection
stla/stlb and lt genes [41]
Diffusely adherent
E. coli (DAEC)
-a HEp-2 cell adherence
assay (following
incubation in Luria
broth)
- daaD gene [42]
Mycobacterium
tuberculosis and
atypical
mycobacteria
- Histopathological
examination of
intestinal biopsies
Culture of biopsy
material
• Interferon-gamma-
release assay (IGRA) on
heparinised blood
samples
Nucleic acid amplification tests
(lacks sensitivity for diagnosis of
extrapulmonary tuberculosis)
[43,44]
- Acid-fast stain (e.g.
Ziehl-Neelsen, Kinyoun,
Auramin)
• Tuberculin skin test
Plesiomonas
shigelloides
-a Culture on CIN agar - -
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biological testing has revolutionized the diagnostic algo-
rithms for the other diarrhoeagenic E. coli. Modern
multiplex PCR assays targeting unique genes of EHEC/
STEC, EIEC, EPEC and ETEC allow a rapid molecular
characterisation of these pathogenic strains. Hence,
multiplex PCR assays have become the test of choice
with excellent sensitivity and specificity (>99%) [42]. In-
deed, these tests have overcome important drawbacks of
the classical stool culture, which often detects only some
important strains (e.g. in the case of EHEC the O157:H7
strain on Sorbitol-MacConkey agar), but misses others
that lack characteristic biochemical properties [39].
However, the integration of such multiplex PCR assays
into routine testing of clinical samples remains restricted
to well-equipped laboratories, and hence, these molecu-
lar techniques are only rarely available in endemic set-
tings in the tropics.
Mycobacterium tuberculosis and atypical mycobacteria
(e.g. M. avium)
Gastrointestinal tuberculosis is the sixth most common
manifestation of extrapulmonary tuberculosis and causes
considerable morbidity, including persistent diarrhoea
and abdominal pain [112]. Atypical mycobacteria (syn-
onymous: mycobacteria other than tuberculosis,
MOTT), particularly M. avium, are an important cause
of long-lasting diarrhoea and gastrointestinal complaints
in HIV-infected individuals. Accurate diagnosis is diffi-
cult and relies on in-depth analysis of intestinal biopsy
specimens by histopathological examination, microscopy
after acid-fast staining (e.g. Ziehl-Neelsen, Auramin or
Kinyoun techniques) and culture on selective media suit-
able for mycobacteria. Unless performed using oil
immersion, histopathology often fails to distinguish be-
tween gastrointestinal tuberculosis and other granu-
lomatous disorders, such as Crohn’s disease [113,114].
An important drawback when culturing mycobacteria is
their slow growth; it might take up to six weeks until
cultures become positive. However, culture is the most
sensitive technique and remains the diagnostic ‘gold’
standard [115]. Different molecular biological assays
have been developed for various mycobacteria, but lack
sensitivity for extrapulmonary tuberculosis and have not
yet been validated for gastrointestinal tuberculosis [43].
Table 2 Diagnostic tests for important bacterial pathogens that may cause persistent digestive disorders (Continued)
Infectious
pathogen
Diagnostic method
Microscopy Stool culture Immunology Molecular biology (PCR) Reference(s)
Salmonella enterica
(typhoidal and non-
typhoidal serovars)
-a • Cultured from
blood and/or bone
marrow (enteric fever)
• Serotyping of isolates
(Vi antigen)
(Mainly for research
purpose)
[45-47]
• Cultured from stool
or duodenal aspirate
(typhoidal and non-
typhoidal
salmonellosis)
• ELISA: detection of
S. typhi antigens (blood)
• Widal agglutination
test (commonly used
in Africa)
Shigella dysenteriae,
S. flexneri, S. boydii,
S. sonnei
-a Culture on MAC,
XLD, HE or Leifson
agar
Agglutination tests to
detect serogroup and
serotype
ipaH, ipl genes [48]
Tropheryma whipplei Histopathological
examination of PAS-
stained intestinal
biopsies: sickleform
particle-containing
cells
(Only in highly
specialised
laboratories)
Immunohistochemistry
on PAS-positive biopsy
material
whip1, whip2 genes [49]
Vibrio spp. Darkfield microscopy:
comma-shaped, motile
bacteria (highly
suggestive of Vibrio spp.)
Culture on TCBS
agar
- PCR for species
differentiation
(V. cholerae, V. parahaemolyticus,
V. vulnificus)
[50,51]
Yersinia
enterocolitica,
Y. pseudotuberculosis
-a Culture on CIN agar Serology (important for
diagnosis of
postinfectious
immunological
diseases)
PCR (reference
laboratories and research purposes)
[52]
The laboratory techniques are divided into different categories and recommended tests for each pathogen are highlighted.
a Gram staining of stool samples can be useful to evaluate the presence of leucocytes, but is not helpful to differentiate between pathogenic bacteria and
apathogenic microbial flora.
b Commonly employed selective media for detection of Campylobacter spp. include charcoal-cefoperazone-deoxycholate agar, Campylobacter blood agar plate,
and cefoperazone-vancomycin-amphotericin agar [53].
c Detection of C. difficile in the Gram stain is not adequate to differentiate between clinical infection and simple colonisation with C. difficile [54].
d Commonly employed selective media for growth of S. enterica are MAC, XLD, HE, Leifson agar or other chromogenic media.
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Table 3 Diagnostic tests for important intestinal protozoa that may cause persistent digestive disorders
Infectious
pathogen
Diagnostic method
Microscopy Stool culture Immunology Molecular
biology (PCR)
Reference(s)
Balantidium coli Stool microscopy - - - [55]
• Wet mount smears
(unstained or iodine
stain)
• Concentration
techniques (e.g. formalin-
ether)
• Permanent stains (e.g.
with iron hematoxylin)
Blastocystis hominis Stool microscopy Stool culture on selective
liquid media (no routine
procedure, but beneficial in
microscopically uncertain
cases)
(No routine procedure) (PCR mainly
applied in
research
settings)
[56-58]
• Wet mount smears
(unstained or iodine
stain)
• Permanent stains (e.g.
with trichrome, iron
hematoxylin, Giemsa)
Cryptosporidium
spp.
Stool microscopy (No routine procedure) • ELISA: faecal antigen
detection
PCR (in
reference
laboratories and
for species
differentiation)
[59-62]
• Wet mount smears
(unstained or iodine stain) • Fluorescence microscopy
• Various staining
techniques, especially
acid-fast stains (e.g.
Kinyoun, modified Ziehl-
Neelsen)
Cyclospora
cayetanensis
Stool microscopy (No routine procedure) - PCR (in
reference
laboratories)
[63]
• Wet mount smears
(light or epifluorescence
microscopy)
• Concentration
techniques (e.g. formalin-
ether)
• Acid-fast stains (oocysts
are variably acid-fast)
Dientamoeba
fragilis
Stool microscopy on
stained smears (e.g. iron-
hematoxylin, chlorazol
black dye stain)
(No routine procedure) - PCR (in
reference
laboratories) on
unpreserved
stool samples
[64,65]
Entamoeba
histolytica
Stool microscopy (No routine procedure) • ELISA: faecal antigen
detection able to distinguish
between E. histolytica and
E. dispar/moshkovskii (stool)
PCR (in
reference
laboratories)
[66-70]
• Wet mount smears
(trophozoites)
• Serological antibody
detection tests (blood samples)
• Formalin-ether
concentration (cysts)
• Permanent stains
Giardia intestinalis Stool microscopy (No routine procedure) • ELISA: faecal antigen
detection
PCR (in
reference
laboratories)
[60,71]
(syn.: G. lamblia
and G. duodenalis) • Wet mount smears
(trophozoites)
• Formalin-ether
concentration (cysts)
• Permanent stains
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Tropheryma whipplei
Whipple’s disease due to infection with T. whipplei is a
rare disease characterised by chronic diarrhoea, wasting,
abdominal pain, arthralgia and various other symptoms
associated with organ involvement (e.g. encephalitis and
endocarditis) [49]. The infectious agent was not identi-
fied until 1961 and many epidemiological and biological
features still need to be elucidated [116]. Only highly
specialised laboratories are able to grow T. whipplei on
human fibroblast cells [117,118]. The development of a
PCR assay targeting the genes whip1 and whip2 has
been a major step forward and is nowadays the test of
choice, especially in symptomatic patients without
typical histopathological findings in intestinal biopsies
(sickleform particle-containing cells on periodic acid-
Schiff (PAS-)stained biopsy specimens) [49].
Parasitic pathogens: intestinal protozoa
Balantidium coli, Blastocystis hominis, Cryptosporidium
spp., Cyclospora cayetanensis, Dientamoeba fragilis,
Entamoeba histolytica, Giardia intestinalis (syn.: G. lamblia
and G. duodenalis), Isospora belli (syn.: Cystoisospora belli),
species of microsporidia
The three main techniques for the diagnosis of human in-
testinal protozoan infections include (i) light microscopy;
(ii) antigen detection (EIAs); and (iii) PCR assays. Since the
first description of parasitic intestinal protozoa in human
stools, documented by the Dutch microscopist Antony van
Leeuwenhoek in 1681 [119], microscopic detection of
protozoan cysts and trophozoites has been the most widely
used diagnostic approach. On fresh stool samples, direct
microscopy is performed by mixing a small amount of fae-
ces with a physiological 0.9% sodium chloride (NaCl) solu-
tion. To increase sensitivity, various stool concentration
techniques have been developed, making use of either sedi-
mentation or flotation with a formalin-ether concentration
technique being the most widely used method in medical
laboratories [120,121]. However, the formalin-ether concen-
tration technique lacks sensitivity for several intestinal
protozoan species as well as many helminths (described
below), and hence there is a pressing need for new and
more sensitive microscopic techniques (e.g. FLOTAC)
[122] and non-microscopic diagnostics. Staining techniques
can be helpful for microscopic parasite identification and
might further improve the diagnostic accuracy. Indeed,
some intestinal protozoan species require staining of the
stool sample to be identified on microscopic examination.
For example, acid-fast stains allow detection of Cryptospor-
idium spp., while species of microsporidia are best seen
when using an Uvitex B or Calcofluor White stain. Still, cor-
rect identification of intestinal protozoan pathogens is chal-
lenging even for experienced laboratory technicians and for
some species even impossible (e.g. E. histolytica based on
cysts morphology). For Cryptosporidium spp., E. histolytica
and G. intestinalis, sensitive EIAs detecting species-
specific antigens in faecal samples have been developed,
some of which are highly sensitive and complement
microscopic stool examination in many clinical laborato-
ries [123,124]. Especially for the diagnosis of E. histolytica,
species differentiation based on alternative procedures is
compulsory, since microscopy cannot readily distinguish
between E. histolytica and the non-pathogenic E. dispar
[66,125,126]. Of note, not all commercially available EIA
antigen detection kits are E. histolytica-specific and some
lack sensitivity, in particular if faecal samples have been
stored for several days [67,127]. Over the past several
years, highly sensitive PCR assays have been developed
and standardised for many intestinal protozoan species.
Table 3 Diagnostic tests for important intestinal protozoa that may cause persistent digestive disorders (Continued)
Infectious
pathogen
Diagnostic method
Microscopy Stool culture Immunology Molecular
biology (PCR)
Reference(s)
Isospora belli (syn.:
Cystoisospora belli)
Stool microscopy - - PCR (in
reference
laboratories)
[60,72,73]
• Wet mount smears
• Concentration techniques
(e.g. formalin-ether)
• Acid-fast stains
Species of
microsporidia
(Enterocytozoon
bieneusi,
Encephalitozoon
spp.)
• Transmission electron
microscopy (gold standard,
but not feasible as routine
test)
- Serology: anti-microsporidial
antibodies (indirect
immunofluorescence assay)
PCR (in
reference
laboratories)
[60,74-76]
- Light microscopy (e.g.
Uvitex B, Chromotrope R or
Calcofluor White stain)
The laboratory techniques are divided into different categories and recommended tests for each pathogen are highlighted.
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Table 4 Diagnostic tests for important helminths that may cause persistent digestive disorders
Infectious pathogen Diagnostic method
Microscopy Stool culture Immunology Molecular biology (PCR) Reference(s)
Cestodes
Diphyllobothrium latum Stool microscopy:
identification of eggs or
proglottids
- - PCR and sequencing for species
differentiation (for
epidemiological purpose)
[77,78]
• Wet preparation
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Sedimentation
techniques
Hymenolepis spp. Stool microscopy - - PCR in research settings (for
epidemiological purpose)
[79]
• Kato-Katz method
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Sedimentation
techniques
• FLOTAC
Taenia spp. Stool microscopy - • Coproantigen EIA PCR for species differentiation [80]
• Perianal egg detection • Serology: detection
of specific circulating
antibodies against
T. solium
• (Graham’s test applying
adhesive tape)
• Examination of tapeworms
from purges
Nematodes
Ascaris lumbricoides Stool microscopy: egg
detection
- - PCR in research settings (for
epidemiological purpose)
[81-83]
• Kato-Katz method
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Sedimentation
techniques
• FLOTAC
Capillaria philippinensis Stool microscopy: egg
detection
- - - [84,85]
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Sedimentation
techniques
• (Kato-Katz method: great
care is indicated to distinguish
between T. trichiura and
C. philippinensis eggs)
Hookworms
(Ancylostoma
duodenale, Necator
americanus)
Stool microscopy: egg
detection
Culture on Koga agar
and subsequent
microscopic
identification of
larvae
PCR mainly applied in research
settings (for epidemiological
purpose)
[81-83]
• Kato-Katz method
• Ethyl-acetate or formalin-
ether-based concentration
techniques
• Sedimentation techniques
• FLOTAC
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Many of these assays (e.g. Entamoeba spp. differentiation
by PCR) are currently being integrated into parasitological
reference laboratories as an additional diagnostic tool to
prove diagnosis in uncertain clinical cases [59,128,129].
Such molecular biological tools are of enormous import-
ance to improve the correct species identification of many
intestinal parasites, which are difficult to diagnose using
conventional techniques [60,74].
Parasitic pathogens: helminths
Ascaris lumbricoides, Capillaria philippinensis,
Diphyllobothrium spp., Hymenolepis spp., hookworm
(Ancylostoma duodenale and Necator americanus), Taenia
spp., Trichuris trichiura, intestinal flukes
Identification of helminth eggs on microscopic stool exam-
ination is the reference test for most intestinal helminth
species. In hospitals and microbiological laboratories,
Table 4 Diagnostic tests for important helminths that may cause persistent digestive disorders (Continued)
Infectious pathogen Diagnostic method
Microscopy Stool culture Immunology Molecular biology (PCR) Reference(s)
Strongyloides stercoralis • Stool: microscopy
following Baermann
funnel concentration
Culture on Koga
agar and
subsequent
microscopic
identification of
larvae
• ELISA tests
detecting serum
antibodies or faecal
antigens
PCR applied in research
settings (for epidemiological
purpose) and increasingly used
for individual patient
management
[86,87]
• Microscopy of sputum,
bronchoalveolar lavage,
duodenal aspirate, skin
biopsy
• Indirect fluorescent
antibody test
Trichuris trichiura Stool microscopy: egg
detection
- - - [81,82]
• Kato-Katz method
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Sedimentation
techniques
• FLOTAC
Trematodes
Intestinal flukes Stool microscopy: egg
detection
- ELISA to detect
worm-specific
antibodies or
antigens in serum or
stool
PCR applied in research
settings (for epidemiological
purpose)
[88]
• Kato-Katz method
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Stoll’s dilution
• Sedimentation
techniques
• FLOTAC
Intestinal blood flukes:
Schistosoma mansoni,
S. intercalatum,
S. japonicum,
S. mekongi
Stool microscopy: egg
detection
- - ELISA to detect
serum antibodies or
worm-specific
antigens in serum or
urine
PCR applied in research
settings for epidemiological
purpose and increasingly used
for individual patient
management
[89]
• Kato-Katz method
- RDT to detect CCA
or CAA antigen in
serum or urine (for
S. mansoni)
• Ethyl-acetate or
formalin-ether-based
concentration techniques
• Stoll’s dilution
• Sedimentation
techniques
• FLOTAC (first experiences
for S. mansoni)
Miracidium-hatching test
from stool samples
The laboratory techniques are divided into different categories and recommended tests for each pathogen are highlighted.
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direct stool examination after prior concentration (e.g. by
formalin-ether concentration technique) is most com-
monly employed, while the Kato-Katz thick smear tech-
nique is widely used in epidemiological studies and
anthelminthic drug efficacy evaluations in endemic regions
[81,130-132]. Direct microscopic examination is a cheap
methodology, the microscope slides can rapidly be pre-
pared for examination, and there is no need for sophisti-
cated laboratory equipment. The eggs of most helminth
species parasitising humans can easily be distinguished by
a trained laboratory technician (see Figure 1 for eight
selected helminth eggs). Hence, microscopy remains the
standard reference test for A. lumbricoides, T. trichiura,
hookworm, Capillaria philippinensis, Diphyllobothrium
spp., Hymenolepis spp., Taenia spp. and blood flukes
(Schistosoma spp.) [82,88,133,134]. However, microscopy
is prone to a number of shortcomings. Firstly, microscopy
is not very sensitive and especially infections of light inten-
sity can be missed when only a single stool sample is ana-
lysed [131,135]. Multiple stool sampling, ideally over
several consecutive days, increases the sensitivity [136], as
well as the use of different concentration techniques, which
are based on sedimentation (e.g. formalin-ether concentra-
tion technique), flotation or a combination of both (e.g.
McMaster technique and FLOTAC) [135,137-139].
However, these techniques often require access to the
power grid, a centrifuge and different chemical reagents,
which are not always available in tropical settings. More-
over, the diagnostic sensitivity for different helminth species
often varies considerably, and no currently available con-
centration technique is able to concurrently detect intes-
tinal protozoa and helminths with the same diagnostic
accuracy [122,140].
Secondly, microscopy results heavily depend on the
quality of the slide preparation and on the experience of
the laboratory technician reading the slides. Thirdly, the
eggs of some helminth species such as the two hookworm
species A. duodenale and N. americanus are virtually in-
distinguishable by microscopy. Fourthly, the nematode
Strongyloides stercoralis can rarely be found when using
the aforementioned microscopy techniques, because its
larvae already hatch in the intestine and, hence, the eggs
are not passed in the faeces [141]. Despite all these con-
straints, microscopy is an invaluable tool for diagnostic
medical parasitology.
New molecular techniques, especially PCR assays, still
need to be validated and further developed in different
settings. Disadvantages of current PCR tests are their
high costs, risk of contamination, the need for high-
technology laboratory equipment and constant electric
Table 5 Diagnostic tests for important viral pathogens that may cause persistent digestive disorders
Infectious pathogen Diagnostic method
Electron microscopy Cell culture Immunology Molecular
biology (PCR)
Reference(s)
Viruses
Adenovirus Low sensitivity
(>106 viral particles/ml)
A549-, HEp-2-, HEK-cells Antigen detection in faecal samples
(ELISA, immunochromatography)
PCR [90]
Astrovirus Low sensitivity
(>106 viral particles/ml)
CaCO-2-, LLC-MK2-cells Antigen detection (ELISA) RT-PCR [91]
Bocavirus - - - PCR [92]
Coronavirus - - - RT-PCR [93]
Cytomegalovirus (CMV) - HFF-, MRC-5 cells • pp65 antigen detection
(immunofluorescence)
PCR [91]
CMV-immediate early1-
pp72-antigen in HFF
• (CMV-specific antibody
seroconversion)
Enterovirus - MRC-5-, HEp-2-, Vero-cells - RT-PCR [94]
Human
immunodeficiency virus
(HIV-1/2)
- HUT-78-, CEM-MOLT4-cells • Immunoassay (e.g. 4th
generation)
RT-PCR [95,96]
• Western Blot
Norovirus Sensitivity 105-106
viral particles/ml
- Antigen detection faecal samples
(EIA)
RT-PCR [91]
Parechovirus - - - RT-PCR [97]
Rotavirus Low sensitivity
(>106 viral particles/ml)
MA104-, CaCO-2-cells Antigen detection in faecal samples
(ELISA), rapid tests (ELISA,
immunochromatography)
RT-PCR [91]
Sapovirus - - - RT-PCR [91]
The laboratory techniques are divided into different categories and recommended tests for each pathogen are highlighted.
RT-PCR, reverse transcriptase-polymerase chain reaction.
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power supply which render their use for routine testing
in many developing countries impossible. Indeed, PCR is
seldom available in the most affected regions, and its
results often do not guide clinicians’ decisions, as em-
piric treatment with albendazole and mebendazole is
commonly employed and effective against many hel-
minth species in endemic areas [7]. Due to the variety of
intestinal parasites causing digestive disorders, a multi-
plex real-time PCR targeting a host of various pathogens
is much more desirable than individual PCR assays for
each parasite, and such multiplex PCRs have been suc-
cessfully developed and are increasingly used in refer-
ence laboratories in industrialised countries [59,83,142].
However, even these multiplex PCRs can only diagnose
a defined host of targeted pathogens, while microscopy
may sometimes detect unexpected pathogens that would
have been missed by other diagnostic methods.
Strongyloides stercoralis
The diagnosis of S. stercoralis in human stool samples
requires special, often laborious concentration techniques.
Most commonly employed are the Baermann funnel and
the Koga agar plate [143]. The Baermann method is a con-
centration technique based on the nematode’s hydrophily
and thermophily. It provides results within a few hours
and is the technique of choice according to the World
Gastroenterology Organization [144], but there is some
debate whether it is as sensitive as agar plate cultures [86].
Derived from classical charcoal culture assays and its se-
quel, the so-called Harada-Mori culture, Koga and collea-
gues developed a special agar plate to detect S. stercoralis
and hookworm larvae [145]. The agar plates are stored for
48 hours in a humid chamber and the traces of the hel-
minths can then be seen on the agar and the larvae can
easily be collected for microscopic species identification.
In contrast to many other helminth infections, where
exact species identification often is not necessarily
required and clinical symptoms are mild, the recognition
of strongyloidiasis and initiation of an effective treatment
with ivermectin is essential to prevent potentially life-
threatening events due to its ability to cause disseminated
hyperinfection in the immunosuppressed population
[141,146]. Hence, the aforementioned laborious techni-
ques seem to be justified and a combination of the Baer-
mann funnel and the Koga agar plate method may lead to
the most accurate results.
Recently, different PCR assays targeting the helminth’s
18S rRNA [87] or 28S rRNA [147] subunit have been
developed. First results are promising, but still need fur-
ther validation in endemic settings.
Schistosoma mansoni, S. mekongi, S. intercalatum and
S. japonicum
The microscopic detection of blood fluke eggs in stool
specimens still remains the cornerstone of the laboratory
diagnosis of intestinal schistosomiasis, as the specificity
is high and the costs of equipment are relatively low.
However, the sensitivity fluctuates, depending on infec-
tion stage and intensity [148]. Hence, concentration
methods like an ether-concentration, the Kato-Katz
thick smear or the recently developed FLOTAC tech-
nique are important tools to increase sensitivity [89].
Figure 1 Morphological features of selected intestinal helminth eggs diagnosed using the formalin-ether concentration technique and
standard light microscopy: A, Schistosoma mansoni; B, Ascaris lumbricoides; C, hookworm; D, Diphyllobothrium latum; E, Trichuris
trichiura; F, Capillaria spp..; G, Taenia spp.; H, Enterobius vermicularis.
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Moreover, examination of multiple (preferably at least
three) stool samples collected on consecutive days is
recommended [136,149]. In contrast to other helminth
infections, immunological RDTs have been developed
for detection of intestinal (S. mansoni) and urogenital
schistosomiasis (S. haematobium). Worm-gut associated
glycoproteins, namely circulating cathodic antigen
(CCA) and circulating anodic antigen (CAA), can be
detected in the serum and the urine of S. mansoni-
infected individuals using genus-specific monoclonal
antibodies [150,151]. Immunochromatographic point-of-
care (POC) dipstick or cassette tests for rapid diagnosis
of S. mansoni via CCA detection in the urine are cur-
rently being validated in different epidemiological set-
tings and will potentially become a valuable tool for
non-microscopic diagnosis of schistosomiasis in epi-
demiological studies and clinical practice. Recent studies
suggest that the diagnostic accuracy of a single POC-CCA
test is considerably more sensitive than a single Kato-Katz
thick smear and that a concurrent S. haematobium infec-
tion does not influence the POC-CCA test results for S.
mansoni diagnosis, which is an important observation due
to the co-endemicity of both blood fluke infections in
many tropical areas [152,153]. Hence, antigen RDT assays
will likely find their way into clinical practice in the fore-
seeable future.
PCR assays have been developed and are more sensi-
tive than conventional parasitological and serological
methods, but presently, their use is restricted to specia-
lised reference laboratories and research institutions out-
side endemic areas [154,155].
Viruses
Viral infections commonly cause acute gastroenteritis
with the highest burden concentrated in tropical and
subtropical regions of the world. Even though these
pathogens mainly lead to short-lasting and self-limiting
diarrhoeal diseases, they account for considerable mor-
bidity and even mortality, particularly in children [156].
In general, viral infections rarely cause chronic intestinal
diseases, but must not be forgotten as potential patho-
gens that may give rise to persistent diarrhoea and
chronic abdominal pain, particularly in HIV-infected
individuals or otherwise immunocompromised hosts.
Traditionally, diagnosis of viral gastroenteritis is based
on virus isolation by cell culture, electron microscopy
and rapid antigen tests (e.g. latex agglutination or EIAs)
[157]. Introduction of molecular methods led to an ex-
ponential increase in detection rates and the role of
difficult-to-culture pathogens became apparent. From a
technical point of view, most rapid tests can be done at
the bedside, whereas cell culture, electron microscopy
and molecular-based methods require laboratories
with sophisticated equipment, experienced staff and
appropriate biosafety procedures. This certainly limits
the use of the latter methods in resource-constrained
settings. Data on sensitivity and specificity of diagnostic
tools for virus identification in tropical settings are cur-
rently lacking.
Adenovirus
Currently, more than 53 types of adenovirus are recog-
nised which can cause a variety of clinical entities, but
gastroenteritis is predominantly caused by types 40 and 41
[158,159]. In infected individuals, viral particles are shed
in high concentrations. In general, virus isolation followed
by serotyping remains the ‘gold’ standard for the detection
of all serotypes and is possible on different cell lines
(Table 5). Importantly, 293-Graham cells should be used
for stool samples as adenovirus species F (adenovirus
types 40 and 41) can only be cultivated on this cell line.
However, virus isolation is rather laborious and time-
consuming in the face of urgent requests for diagnosis.
Electron microscopy is possible with high specificity, but
low sensitivity. As an alternative method that is particu-
larly useful for examination of stool samples, antigen de-
tection assays using EIA or latex agglutination have been
developed [160,161]. These assays are rapid, but displayed
varying sensitivities and specificities in studies, and hence
should be complemented by alternative methods. Molecu-
lar methods, in particular real-time PCR, have demon-
strated superior performance over conventional methods
and are now the cornerstone for diagnosis in most labora-
tories, but are seldom available in resource-constrained
settings.
Astrovirus
Eight serotypes of astrovirus are known. In childhood,
astrovirus infection with serotypes 1 and 2 predominate,
whereas infection with the other serotypes occurs later
in life (>4 years). Prolonged diarrhoea has been asso-
ciated with astrovirus serotype 3 [162]. In the immuno-
competent host, viral shedding occurs for 14–70 hours
but may be prolonged in immunosuppressed patients.
Virus propagation of astrovirus on CaCO-2 or LLC-
MK2 cells remains restricted to expert laboratories and
is not recommended for routine diagnostic use. Virus
identification by electron microscopy is possible, but ap-
pearance of viral particles is not always clear. Recently
developed antigen detection kits have proven their suit-
ability and are now widely available for rapid diagnosis.
However, sensitivity and specificity of rapid tests in com-
parison to reverse transcriptase (RT)-PCR have been
reported to be comparably low [163]. Real-time RT-PCR
is the most sensitive and specific method, but remains
restricted to reference laboratories.
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Bocavirus
Four different species of human bocavirus (hBoV) have
been described thus far [164]. The diagnosis of hBoV
infection is almost exclusively based on molecular meth-
ods. hBoV has not been isolated by cell culture or in an
animal model and rapid antigen tests are currently not
available. Serology (e.g. using viral-like particles) has been
described and can be used to complement diagnosis [165].
A variety of PCR and real-time PCR assays have been
described. However, due to prolonged detection of viral
DNA at low copy numbers, qualitative detection of hBoV
DNA in gastrointestinal samples is not recommended.
There are only few data available for hBoV species 2–4
and the relevance as a true human pathogen is still under
debate [164].
Calicivirus
The family calicivirus comprises two human-pathogenic
genera, the norovirus and sapovirus [166]. For both gen-
era, virus isolation by cell culture is not possible. Elec-
tron microscopy is rather insensitive and rarely detects
the viruses if there are fewer than 106 viral particles/ml
of stool suspension.
Norovirus Antigen EIAs have been developed and are
commercially available for rapid diagnosis. They proved
to be a valuable tool especially in outbreaks, but their
sensitivity is limited [167]. A recent study from Brazil
reported a sensitivity of 87.9% upon use of a 3rd gener-
ation norovirus antigen detection kit [168]. More re-
cently, real-time RT-PCR assays have been described
and demonstrated excellent sensitivity and specificity
[169]. In-house methods as well as commercial kits are
widely available and routinely used.
Sapovirus Specific real-time RT-PCR assays have been
developed, but there are no comprehensive data evaluat-
ing their diagnostic accuracy. However, there are no
diagnostic alternatives because rapid antigen tests are
not yet available.
Coronavirus
Five different human pathogenic coronaviruses are
known which can cause respiratory and/or to a lesser ex-
tent gastrointestinal symptoms in humans. However, the
relevance of coronavirus as a true human enteric patho-
gen is unclear [93,170]. Conventional virus isolation by
cell culture can be done on human embryonal tracheal
cells. Electron microscopy is possible for stool samples
but displays rather low sensitivity. For coronavirus, anti-
gen tests for stool samples are not available. Molecular
methods, e.g. real-time RT-PCR assays are the method
of choice for a reliable and rapid diagnosis. However,
most in-house methods are restricted to reference la-
boratories, and hence are not commonly employed
around the globe.
Cytomegalovirus
In particular immunosuppressed patients are at risk for
cytomegalovirus (CMV) infection, which can affect vari-
ous organ systems, including the gastrointestinal tract
[158,171]. Serology represents the method of choice to
differentiate primary from secondary infection. Organ-
specific diagnosis (e. g. CMV-associated gastrointestinal
disease) requires tissue biopsy samples. In combination
with histopathology, isolation of CMV by cell culture is
recommended. Detection of CMV-DNA by molecular
methods alone is not sufficient.
Enterovirus
Enteroviruses belong to the family picornaviridae and
comprise enterovirus group A to D [172]. In general,
enteroviruses can cause a broad spectrum of different
clinical entities. Gastroenteritis caused by coxsackievirus
A is mostly seen in children. Virus isolation is possible
on a range of different cell lines (Table 5). Virus typing
after isolation is traditionally accomplished by virus neu-
tralisation. Of note, enteroviruses may be shed into the
stool for prolonged time after clearance of acute infec-
tion, thus limiting the significance of such a finding. RT-
PCR methods are now widely available for the detection
of viral genomes. However, sequence variation among
the different enterovirus groups can lower the specificity
and PCR-based assays should regularly be updated using
latest sequence information. Serological methods for the
detection of enterovirus-specific antibodies are exclu-
sively available in reference laboratories and cannot be
used for rapid diagnosis.
Parechovirus
Parechoviruses have gained recent interest, but their role
in acute gastroenteritis and persistent diarrhoea has yet to
be established [173,174]. At the time of writing, 16 pare-
choviruses types have been described. They now represent
an own genus within the familiy picornaviridae and real-
time RT-PCR is the method of choice for diagnosis in
high-income settings [175].
Human rotavirus
Rotavirus infection alone is believed to account for 453,000
deaths annually in children younger than 5 years [5]. In
most cases, infection causes acute diarrhoea and vomiting
with viral particles being shed in high concentrations. Virus
isolation is possible on MA104 or CaCO-2-cells but
remains laborious and time-consuming. Antigen detection
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by EIA methods is the current standard procedure for the
rapid diagnosis of rotavirus infection and widely available
for diagnosis as well as surveillance. These assays are able
to detect virus particles even if their concentration is below
104 particles/ml stool suspension. Molecular methods are
also available [176,177].
HIV-associated enteropathy
HIV-associated enteropathy frequently occurs in HIV-
infected individuals without access to antiretroviral ther-
apy and is characterised by persistent diarrhoea, weight
loss, anorexia, abdominal pain and dysphagia. HIV-
associated enteropathy should be diagnosed by obtaining
intestinal biopsies via endoscopy with subsequent histo-
logical and microbiological examination [178]. Anti-
retroviral treatment of the HIV infection usually also
cures the enteropathy.
Discussion
Persistent digestive disorders are unspecific clinical com-
plaints which are commonly reported by many patients
around the world. Gastrointestinal or systemic infections
are important causes of such disorders with a broad
spectrum of possible pathogens involved, including bac-
teria, intestinal protozoa, helminths and viruses. Due to
the wide range of infectious agents which are often diffi-
cult to diagnose, great efforts have to be made to reach
satisfactory detection rates and to avoid overlooking of im-
portant pathogens. Such a diagnostic work-up should in-
clude bacterial stool cultures on different selective media
(including MacConkey, sorbitol-MacConkey, Leifson and
other agar plate cultures), microscopic examination of un-
stained (e.g. direct faecal smear, Kato-Katz thick smear
and formalin ether-concentration method) and stained
microscope slides (acid-fast stains, e.g. Kinyoun technique)
for parasite identification, and various pathogen-specific
tests such as PCR for viruses and diarrhoeagenic E. coli
pathotypes, toxin detection kits for C. difficile diagnosis,
and stool concentration methods for S. stercoralis (e.g.
Baermann funnel and Koga agar plate). Examination of
more than one stool specimen over consecutive days is
crucial, because many intestinal pathogens are irregularly
shed in the faeces [149]. ‘Classical’ approaches to persist-
ent diarrhoea often lead to disappointing results with up
to 80% of cases in which no causative pathogen can be
determined [6].
However, even exhaustive laboratory work-up is prone
to a host of limitations and challenges that must be consid-
ered and addressed. Firstly, gastrointestinal complaints are
often caused by non-infectious causes, and a combination
of different clinical signs and symptoms as well as further
tests are needed to detect and exclude such non-infectious
aetiologies. Secondly, available epidemiological data
regarding the sought infectious pathogens in the tropics
are scarce, thus requiring broad diagnostic testing to avoid
overlooking of important pathogens. Thirdly, studies
should be carried out in different social-ecological settings
to assess the influence of cultural, demographic, genetic,
geographic, socioeconomic and health system related fac-
tors on predominating pathogens. Fourthly, such research
must address all pathogen classes and should not be lim-
ited to one-dimensional approaches examining either bac-
teria or parasites only. Fifthly, there are certain issues
unique to gastrointestinal diseases which clearly distin-
guish them from other organ disorders; most importantly,
the finding of a given pathogen may not necessarily mean
that the patient’s complaints are caused by this organism
[179]. Bacteria, helminths and intestinal protozoa may
often be found as harmless commensals or even beneficial
parts of the gastrointestinal flora, and thus such findings
may represent coincidence rather than causality [180-182].
This is of particular importance when different potential
pathogens are found concurrently in one faecal specimen
and the causative one(s) have to be differentiated. Sixthly,
even primarily non-intestinal infectious pathogens may
cause gastrointestinal symptoms, as has been reported for
HIV infection and even malaria in the tropics, where acute
or long-lasting diarrhoea may be the only symptom in
up to 20% of all observed cases [183,184]. In contrast,
patients may as well start to complain about reduced well-
being and develop clinical symptoms only some weeks to
months after clearance of an intestinal pathogen, as is the
case in postinfectious irritable bowel syndrome [185].
Finally, the variety of possible pathogens affecting the gut
is so exhaustive that even very sophisticated diagnostic
approaches will not be able to detect every pathogen with
satisfactory sensitivity and specificity, especially when con-
sidering the cost and practical applicability of some spe-
cialised techniques that are not currently feasible in most
parts of the tropics.
Conclusion
There is a pressing need for research targeting persistent
digestive disorders as a coherent clinical problem rather
than as a disconnected collection of pathologies. This
would allow the elaboration of evidence-based diagnosis-
treatment algorithms centred on patients in resource-
constrained settings, where data availability is scarce and
patient management often driven by experience and local
beliefs. This is the overarching goal of the NIDIAG con-
sortium, focusing on digestive disorders as discussed here,
as well as on neurological disorders [23] and persistent
fever [24]. Additionally, such investigations will optimise
the use of existing diagnostic tests and advance the deve-
lopment of new methods, which are ideally able to con-
currently detect a broad spectrum of intestinal pathogens
with a high sensitivity and specificity, and which are
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simple and affordable enough to be performed in low-
income countries where prevalences of persistent digestive
disorders are generally high. Moreover, the thorough
evaluation of reference tests for intestinal pathogens can
serve as diagnostic ‘gold’ standard in the standardisation
and validation of easily applicable RDTs, which are highly
needed tools in resource-constrained field settings. Finally,
such in-depth investigations are not only important for in-
dividual patient management, but also for public health
policy making (e.g. to assess the efficacy and cost-
effectiveness of ongoing preventive chemotherapy control
programmes targeting helminthiases). There is a need for
improved diagnostics for persistent digestive disorders in
the tropics. It is desirable to conduct a multicentric study
to investigate the clinical presentations and respective
identified pathogens of large patient cohorts presenting
with non-acute gastrointestinal diseases as a first step to-
wards more reliable and evidence-based clinical case man-
agement in the tropics.
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